BioWorld

Nov. 22, 2004

View Archived Issues

Stock Winners and Losers For The Week

Biotechnology Company Deals With Other Biotechnology Companies: Collaborations, Agreements, Equity Participation, Sept. 17 - Nov. 17, 2004

Manufacturing, Marketing And Distribution Agreements Between Biotech Companies: Sept. 17 - Nov. 17, 2004

Biotechnology Company Deals With Miscellaneous Companies: Collaborations, Agreements, Equity Participation, Sept. 17 - Nov. 17, 2004

Biotech-Biotech Collaborations: Modified And Terminated Agreements, Sept. 17 - Nov. 17, 2004

BioWorld Stock Report For Public Biotechnology Companies

Use Of Velcade Widening As Various Trials March On

When Millennium Pharmaceuticals Inc. nailed down its overseas marketing deal in July 2003 with Ortho Biotech Products LP for the multiple myeloma drug Velcade (approved two months earlier), investors sat up and took notice. (BioWorld Financial Watch) Read More

Money Raised Year To Date

Today's news in brief

BioWorld

BioWorld briefs for June 10, 2026.

News in brief

BioWorld Asia

BioWorld Asia briefs for June 9, 2026

3D rendering of β2-Adrenergic receptor GPCR protein molecule embedded in lipid bilayer membrane.

Skape Bio unlocks GPCR targets with de novo-designed miniproteins

BioWorld

Modulating G protein-coupled receptors (GPCRs) is one of the major challenges in biomedicine. These are flexible proteins with small, deep binding pockets. The...

Antares Therapeutics divulges new CDK2/cyclin E1 inhibitors

BioWorld Science

Antares Therapeutics Inc. has reported new CDK2/cyclin E1 inhibitors potentially useful for the treatment of cancer.

Wuxi Apptec insists it’s ‘not a Chinese military company’

BioWorld

Wuxi Apptec isn’t going down without a fight after the U.S. Department of Defense added it to the Section 1260H list June 8 as a designated “Chinese military...